20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
Our tradition includes using our first January post to make predictions about “what’s to come” in...
Read More >
In line with recently passed legislation in New York and California, Illinois’ legislature rallied ...
Read More >
The Securities and Exchange Commission (the "SEC") recently adopted amendments to Regulation S-X and...
Read More >
We all know that when we make a mistake, it’s best that we correct them. Yet too many plan sponsors...
Read More >
On October 4, 2019, the Ninth Circuit Court of Appeals affirmed rulings by the District Court for th...
Read More >
Substantially overhauling its labor law, Mexico has enacted legislation that prohibits employer inte...
Read More >